{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:05:01Z","timestamp":1793124301369,"version":"4.5.0"},"reference-count":38,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2024,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The aims of this study were to investigate incidence, risk factors and treatment of synchronous or metachronous peritoneal metastases (PM) from gastric cancer and to estimate survival of these patients using population\u2010based data. Patients diagnosed with gastric cancer in 2015 to 2016 were selected from the Netherlands Cancer Registry. The incidence of synchronous and metachronous PM were calculated. Multivariable regression analyses were performed to identify factors associated with the occurrence of PM. Treatment and survival were compared between patients with synchronous and metachronous PM. Of 2206 patients with gastric cancer, 741 (34%) were diagnosed with PM. Of these, 498 (23%) had synchronous PM. The cumulative incidence of metachronous PM in patients who underwent potentially curative treatment (n\u2009=\u2009675) was 22.8% at 3\u2009years. A factor associated with synchronous and metachronous PM was diffuse type histology. Patients diagnosed with synchronous PM more often received systemic treatment than patients with metachronous PM (35% vs 18%, respectively,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u2009.001). Median overall survival was comparable between synchronous and metachronous PM (3.2 vs 2.3\u2009months, respectively,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u2009.731). Approximately one third of all patients with gastric cancer are diagnosed with PM, either at primary diagnosis or during 3\u2010year follow\u2010up after potentially curative treatment. Patients with metachronous PM less often received systemic treatment than those with synchronous PM but survival was comparable between both groups. Future trials are warranted to detect gastric cancer at an earlier stage and to examine strategies that lower the risk of peritoneal dissemination. Also, specific treatment options for patients with gastric PM should be further investigated.\n                  <\/jats:p>","DOI":"10.1002\/ijc.34780","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T08:45:51Z","timestamp":1698914751000},"page":"992-1002","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Peritoneal metastases from gastric cancer in a nationwide cohort: Incidence, treatment and survival"],"prefix":"10.1002","volume":"154","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0556-3828","authenticated-orcid":false,"given":"Anouk","family":"Rijken","sequence":"first","affiliation":[{"name":"Department of Surgery Catharina Hospital  Eindhoven the Netherlands"},{"name":"Department of Research and Development Netherlands Comprehensive Cancer Organization (IKNL)  Utrecht the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9054-7541","authenticated-orcid":false,"given":"Marieke","family":"Pape","sequence":"additional","affiliation":[{"name":"Department of Research and Development Netherlands Comprehensive Cancer Organization (IKNL)  Utrecht the Netherlands"},{"name":"Amsterdam UMC location University of Amsterdam Medical Oncology  Amsterdam the Netherlands"},{"name":"Cancer Center Amsterdam, Cancer Treatment and Quality of Life  Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert A.","family":"Simkens","sequence":"additional","affiliation":[{"name":"Department of Surgery Catharina Hospital  Eindhoven the Netherlands"},{"name":"Department of Surgery and Cancer Imperial College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignace H. J. T.","family":"de Hingh","sequence":"additional","affiliation":[{"name":"Department of Surgery Catharina Hospital  Eindhoven the Netherlands"},{"name":"Department of Research and Development Netherlands Comprehensive Cancer Organization (IKNL)  Utrecht the Netherlands"},{"name":"GROW\u2014School for Oncology and Development Biology Maastricht University  Maastricht the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misha D. P.","family":"Luyer","sequence":"additional","affiliation":[{"name":"Department of Surgery Catharina Hospital  Eindhoven the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna W.","family":"van Sandick","sequence":"additional","affiliation":[{"name":"Department of Surgery Antoni van Leeuwenhoek \u2013 Netherlands Cancer Institute  Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke W. M.","family":"van Laarhoven","sequence":"additional","affiliation":[{"name":"Amsterdam UMC location University of Amsterdam Medical Oncology  Amsterdam the Netherlands"},{"name":"Cancer Center Amsterdam, Cancer Treatment and Quality of Life  Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob H. A.","family":"Verhoeven","sequence":"additional","affiliation":[{"name":"Department of Research and Development Netherlands Comprehensive Cancer Organization (IKNL)  Utrecht the Netherlands"},{"name":"Amsterdam UMC location University of Amsterdam Medical Oncology  Amsterdam the Netherlands"},{"name":"Cancer Center Amsterdam, Cancer Treatment and Quality of Life  Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0125-1429","authenticated-orcid":false,"given":"Felice N.","family":"van Erning","sequence":"additional","affiliation":[{"name":"Department of Surgery Catharina Hospital  Eindhoven the Netherlands"},{"name":"Department of Research and Development Netherlands Comprehensive Cancer Organization (IKNL)  Utrecht the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31288-5"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-018-6627-y"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/17588359221085557"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-021-01160-1"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.23633"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5640-2"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2020.05.021"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.77.8613"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10214882"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28373"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.26210"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10740"},{"key":"e_1_2_12_15_1","unstructured":"FritzA ConstanceP AndrewJ ShanmugaratnamK SobinLH.International classification of diseases for oncology 3rd edn. World Health Organization.2000."},{"key":"e_1_2_12_16_1","volume-title":"TNM Classification of Malignant Tumours","author":"International Union against Cancer (UICC)","year":"2009"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2022.03.003"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/apm.1965.64.1.31"},{"key":"e_1_2_12_19_1","unstructured":"Sample Size Calculators.2023.https:\/\/sample-size.net\/sample-size-survival-analysis"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2022.11.093"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-017-5838-y"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-013-0306-2"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13184626"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2016.4337"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2020.101846"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0000000000000250"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.02.017"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.01.031"},{"key":"e_1_2_12_29_1","unstructured":"Federatie Medisch Specialisten.Richtlijnen database. Maagcarcinoom: Follow\u2010up.2023https:\/\/richtlijnendatabase.nl\/richtlijn\/maagcarcinoom\/algemeen.hmtl"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.10527"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-10724-5"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8101685"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-11316-z"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2022.04.018"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471\u20102407\u201014\u2010183"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-1039-7"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.139.1.20"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055531"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32557-1"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.34780","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T23:40:58Z","timestamp":1709854858000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.34780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,3,15]]}},"alternative-id":["10.1002\/ijc.34780"],"URL":"https:\/\/doi.org\/10.1002\/ijc.34780","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]},"assertion":[{"value":"2023-04-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}